Published in PLoS One on March 07, 2016
A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis. Mol Cell (2000) 7.18
Hormesis defined. Ageing Res Rev (2007) 3.00
Prolonged bile duct obstruction: a new experimental model for cirrhosis in the rat. Br J Exp Pathol (1984) 2.63
Human bile salt export pump promoter is transactivated by the farnesoid X receptor/bile acid receptor. J Biol Chem (2001) 2.58
In vitro cytotoxicity assays: comparison of LDH, neutral red, MTT and protein assay in hepatoma cell lines following exposure to cadmium chloride. Toxicol Lett (2005) 2.48
Bile acid transporters. J Lipid Res (2009) 2.31
Resistance of rat hepatocytes against bile acid-induced apoptosis in cholestatic liver injury is due to nuclear factor-kappa B activation. J Hepatol (2003) 2.24
Neutrophils aggravate acute liver injury during obstructive cholestasis in bile duct-ligated mice. Hepatology (2003) 2.00
Bile Acids: The Good, the Bad, and the Ugly. News Physiol Sci (1999) 1.81
Superoxide anions and hydrogen peroxide induce hepatocyte death by different mechanisms: involvement of JNK and ERK MAP kinases. J Hepatol (2005) 1.72
Tauroursodeoxycholic acid protects rat hepatocytes from bile acid-induced apoptosis via activation of survival pathways. Hepatology (2004) 1.37
Recent insights on the mechanisms of liver preconditioning. Gastroenterology (2003) 1.34
Ursodeoxycholate (UDCA) inhibits the mitochondrial membrane permeability transition induced by glycochenodeoxycholate: a mechanism of UDCA cytoprotection. J Pharmacol Exp Ther (1995) 1.32
Farnesoid X receptor and bile salts are involved in transcriptional regulation of the gene encoding the human bile salt export pump. Hepatology (2002) 1.31
Mitochondrially-mediated toxicity of bile acids. Toxicology (2004) 1.26
Oxidative stress and the pathogenesis of cholestasis. Semin Liver Dis (2010) 1.22
Hepatic levels of bile acids in end-stage chronic cholestatic liver disease. Clin Chim Acta (1996) 1.18
Cholestasis. Annu Rev Med (1968) 1.17
Bile salts and cholestasis. Dig Liver Dis (2010) 1.16
Protective effect of ischemic preconditioning on liver preservation-reperfusion injury in rats. Transplantation (1998) 1.14
Bile acid-induced necrosis in primary human hepatocytes and in patients with obstructive cholestasis. Toxicol Appl Pharmacol (2015) 1.13
Effects of bile salts on the plasma membranes of isolated rat hepatocytes. Biochem J (1980) 1.13
New paradigms in the treatment of hepatic cholestasis: from UDCA to FXR, PXR and beyond. J Hepatol (2015) 1.12
Review article: The function and regulation of proteins involved in bile salt biosynthesis and transport. Aliment Pharmacol Ther (2007) 1.11
Molecular mechanisms of hepatic bile salt transport from sinusoidal blood into bile. Am J Physiol (1995) 1.07
Molecular mechanisms of liver preconditioning. World J Gastroenterol (2010) 1.06
Ursodeoxycholic acid for primary biliary cirrhosis. Cochrane Database Syst Rev (2012) 1.05
Human hepatic mitochondria generate reactive oxygen species and undergo the permeability transition in response to hydrophobic bile acids. J Pediatr Gastroenterol Nutr (2005) 1.02
"Let there be bile"--understanding hepatic injury in cholestasis. J Pediatr Gastroenterol Nutr (2006) 0.94
Glutathione status of isolated rat hepatocytes affects bile acid-induced cellular necrosis but not apoptosis. Toxicol Appl Pharmacol (2000) 0.93
Differential activation of the human farnesoid X receptor depends on the pattern of expressed isoforms and the bile acid pool composition. Biochem Pharmacol (2013) 0.92
Activation of the nuclear receptor FXR enhances hepatocyte chemoprotection and liver tumor chemoresistance against genotoxic compounds. Biochim Biophys Acta (2013) 0.91
Opposite effect of oxidative stress on inducible nitric oxide synthase and haem oxygenase-1 expression in intestinal inflammation: anti-inflammatory effect of carbon monoxide. J Pathol (2004) 0.91
Bile acids measured in serum during fasting as a test for liver disease. Clin Chem (1978) 0.90
Stable expression and functional characterization of a Na+-taurocholate cotransporting green fluorescent protein in human hepatoblastoma HepG2 cells. Cytotechnology (2000) 0.90
Sphingosine kinase-1 inhibition protects primary rat hepatocytes against bile salt-induced apoptosis. Biochim Biophys Acta (2013) 0.87
Targeting FXR in cholestasis: hype or hope. Expert Opin Ther Targets (2014) 0.85
Metformin protects primary rat hepatocytes against oxidative stress-induced apoptosis. Pharmacol Res Perspect (2015) 0.83
Metformin protects rat hepatocytes against bile acid-induced apoptosis. PLoS One (2013) 0.83
Intrahepatic cholestatic syndromes: pathogenesis, clinical features and management. Dig Dis (1999) 0.82
Glutathione and antioxidant enzymes serve complementary roles in protecting activated hepatic stellate cells against hydrogen peroxide-induced cell death. Biochim Biophys Acta (2013) 0.81
TNF-α suppression by glutathione preconditioning attenuates hepatic ischemia reperfusion injury in young and aged rats. Inflamm Res (2014) 0.80
Helium preconditioning protects mouse liver against ischemia and reperfusion injury through the PI3K/Akt pathway. J Hepatol (2014) 0.79
Unconjugated bile salts shuttle through hepatocyte peroxisomes for taurine conjugation. Hepatology (2010) 0.79
Effects of hyperbaric oxygen therapy as hepatic preconditioning in rats submitted to hepatic ischemia/reperfusion injury. Acta Cir Bras (2014) 0.79